Percutaneous trans-hepatic cholangioscopy and lithotripsy in the treatment of intrahepatic stones: a study with 5 year follow-up - 12/09/11
Abstract |
Background: Intrahepatic stones are characterized by high treatment failure and recurrence rates. In the past, surgery played a major role in the management of this disease, but surgical intervention may not be feasible in previously operated patients or those classified as poor surgical risks. The development of percutaneous trans-hepatic cholangioscopy and lithotripsy has played an important role in the treatment of these patients.
Methods: We reviewed our results in 165 patients with intrahepatic stones treated by percutaneous trans-hepatic cholangioscopy and lithotripsy in the past 12 years.
Results: The rate of complete stone removal was 80% (132 cases) and the rate of recurrent biliary stones after a mean 58 month follow-up interval was 32.6% (43 of 132 cases). There were 2 deaths during the treatment period and 10 deaths during follow-up.
Conclusions: Percutaneous trans-hepatic cholangioscopy and lithotripsy are good alternatives in treating primary intrahepatic stones, especially for those patients unsuitable for surgery. (Gastrointest Endosc 1995;42:13-8.)
Le texte complet de cet article est disponible en PDF.Plan
 | Reprint requests: Min-Ho Huang, MD, Show-Chwan Memorial Hospital, No. 542, Sec. 1, Chun-San Rd, Chang-hua, Taiwan, R.O.C. |
| 37/1/63949 |
Vol 42 - N° 1
P. 13-18 - juillet 1995 Retour au numéro
Article précédent
- Yield of prospective, noninvasive evaluation of the common bile duct combined with selective ERCP/sphincterotomy in 1390 consecutive laparoscopic cholecystectomy patients
- Roman Rieger, Wolfgang Wayand, From the 2nd Department of Surgery and Ludwig Boltzmann Institute for Laparoscopic Surgery, General Hospital of Linz, Austria.
- Duplex Doppler endosonography in the diagnosis of splenic vein, portal vein, and portosystemic shunt thrombosis
- Maurits J. Wiersema, Amitabh Chak, Kenyon K. Kopecky, Lisa M. Wiersema
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?